Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
200 words
A process for determining the presence of a particular nucleic acid sequence in a sample containing cells comprising (a) chemically modifying nucleic acids in an unpurified sample, said sample consisting essentially of whole cells, said whole cells being lysed during the process, cell lysates and mixtures thereof, either to introduce a label or a reactive site, wherein the chemical modification of the sample nucleic acids to introduce said label or said reactive site is accomplished by reaction with a photochemical reagent comprising said label or reactive site, respectively, (b) conducting hybridization, (c) contacting under hybridization conditions the chemically modified sample nucleic acids with a hybridizable nucleic acid probe which either, when the sample nucleic acids have been modified to introduce a label, includes a reactive site, or when the sample nucleic acids have been modified to introduce a reactive site, is labeled, (d) contacting the solution resulting from step (c) with an immobilized form of a reactive site on the sample nucleic acids or the probe, respectively, (e) separating the resulting immobilized fraction from the remaining solution, and (f) determining the presence of the label in the separated immobilized fraction or a decrease in the label in the remaining solution.
Claim 2
Dependent Claim
200 words
A process for determining the presence of a particular nucleic acid sequence in a sample containing cells comprising (a) chemically modifying nucleic acids in an unpurified sample, said sample consisting essentially of whole cells, said whole cells being lysed during the process, cell lysates and mixtures thereof, either to introduce a label or a reactive site, wherein the chemical modification of the sample nucleic acids to introduce said label or said reactive site is accomplished by reaction with a photochemical reagent comprising said label or reactive site, respectively, (b) conducting hybridization, (c) contacting under hybridization conditions the chemically modified sample nucleic acids with a hybridizable nucleic acid probe which either, when the sample nucleic acids have been modified to introduce a label, includes a reactive site, or when the sample nucleic acids have been modified to introduce a reactive site, is labeled, (d) contacting the solution resulting from step (c) with an immobilized form of a reactive site on the sample nucleic acids or the probe, respectively, (e) separating the resulting immobilized fraction from the remaining solution, and (f) determining the presence of the label in the separated immobilized fraction or a decrease in the label in the remaining solution.
Claim 3
Dependent Claim
17 words
A process according to claim 1, wherein said photochemically reactive reagent is a nucleic acid binding ligand.
Claim 4
Dependent Claim
25 words
A process according to claim 1, wherein the immobilized form of the reactive partner comprises a solid support to which the reactive group is attached.
Claim 5
Dependent Claim
19 words
A process according to claim 1, wherein the reactive site is a binding site capable of specific noncovalent binding.
Claim 6
Dependent Claim
33 words
A process according to claim 4, wherein the binding site is biotin or a hapten and wherein the immobilized reactive partner is an immobilized form of avidin or an anti-hapten antibody reagent, respectively.
Claim 7
Dependent Claim
33 words
A process according to claim 1, wherein the label is selected from the group consisting of an enzymatically active group, a fluorescer, a chromophore, a luminescer, a specifically bindable ligand and a radioisotope.
Claim 8
Dependent Claim
27 words
A process according to claim 1, wherein the label is a specifically bindable ligand and its presence is determined by binding with a labeled binding partner therefor.
Claim 9
Dependent Claim
27 words
A process according to claim 7, wherein the ligand is biotin or a hapten and the binding partner therefor is avidin or an anti-hapten antibody reagent, respectively.
Claim 10
Dependent Claim
24 words
A process according to claim 1, wherein the particular sequence of interest is characteristic of the presence or absence of a particular genetic disorder.
Claim 11
Dependent Claim
14 words
A process according to claim 9, wherein the genetic disorder is sickle cell anemia.
Claim 12
Dependent Claim
42 words
A process according to claim 1, wherein the test sample nucleic acids are chemically modified to introduce a label in step (a) and the resulting labeled sample nucleic acids are contacted in step (b) with a probe that carries a reactive site.
Claim 13
Dependent Claim
40 words
A process according to claim 1, wherein the test sample nucleic acids are chemically modified to introduce a reactive site in step (a) and the resulting reactive site-modified sample nucleic acids are contacted in step (b) with a labeled probe.
Claim 14
Dependent Claim
20 words
A process according to claim 1, wherein the probe has a concentration that is greater than that of the sample.
Claim 15
Dependent Claim
23 words
A process according to claim 13, wherein the concentration of the probe is in excess of the sample by at least 1,000 times.
Claim 16
Dependent Claim
11 words
A process according to claim 1, wherein the cells are lysed.